We also found that CTLA4 and IDO1, two well‐known immune checkpoints, were significantly higher in both tumor tissues and NATs than in healthy tissues, while the expression levels of VEGFB and LAG3 increased progressively in healthy tissues, NATs and tumor tissues. This evidence concerns the gene CTLA4 and neoplasm.